Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis.

Volume: 9, Issue: 4
Published: Aug 1, 2021
Abstract
We aimed to evaluate the quality of clinical evidence that substantiated approval of cancer medicines by the European Medicines Agency (EMA) in the last decade. We performed a systematic review and data synthesis of EMA documents in agreement with PRISMA guidelines. We included the European Public Assessment Reports, Summaries of Product Characteristics, and published randomized controlled trials (RCTs) on anti-cancer drugs approved by EMA from...
Paper Details
Title
Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesis.
Published Date
Aug 1, 2021
Volume
9
Issue
4
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.